Package leaflet: Information for the user Clexane …
• The dose will depend on how likely you are to develop a clot. You will be given 2,000 IU (20 mg) or 4,000 IU (40 mg) of Clexane Syringes each day.
Download Package leaflet: Information for the user Clexane …
Information
Domain:
Source:
Link to this page:
Documents from same domain
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
PACKAGE LEAFLET - Medicines
www.medicines.org.ukPage 2 of 7 Package leaflet: Information for the patient Zopiclone 7.5 mg Film-coated Tablets (zopiclone) Read all of this leaflet carefully before you …
Related documents
Haemodialysis anticoagulation and adequacy
www.cari.org.auThe CARI Guidelines – Caring for Australians with Renal Impairment Dialysis Adequacy – Haemodialysis (July 2005) Haemodialysis anticoagulation and adequacy
DATA SHEET 1 CLEXANE AND CLEXANE FORTE 2 …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 1 . DATA SHEET 1 CLEXANE ® AND CLEXANE ® FORTE * 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
THE LABOUR COURT OF SOUTH AFRICA, CAPE …
www.saflii.orgIntroduction [1] This is an application to have an arbitration award by the third respondent, Leslie Martin (a panellist of the Public Health and Social Development
Clexane (Enoxaparin) Multidose Vial Summary of …
www.sanofi-aventis.co.ukSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Clexane ® Multidose Vial 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Vials containing 300 mg enoxaparin …
SUMMARY OF PRODUCT CHARACTERISTICS 1 …
www.sanofi-aventis.co.ukTreatment of unstable angina and non-Q-wave myocardial infarction The recommended dose is 1 mg/kg Clexane every 12 hours by subcutaneous injection, administered concurrently with oral aspirin (100 to 325mg once